ADMA Biologics (ADMA) logo

ADMA Biologics (ADMA) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 1

One insider bought $251K. No sales.

BuyJerrold B. Grossman$51KDirectorat $7.91 on May 27, filed May 28
BuyJerrold B. Grossman$100KDirectorat $8.01 on May 12, filed May 14
BuyJerrold B. Grossman$100KDirectorat $8.01 on May 11, filed May 12

From SEC Form 4s, the newest filed May 28, 2026 · Insiders have 2 business days to file a trade

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 3 tradesSee it live, free until Friday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on ADMA with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at ADMA Biologics

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about ADMA's insider trades

As of Nov 4, 2026: ADMA Biologics (ADMA) has 3 insider filings on record in the last 6 months, the newest filed May 28, 2026. Its Quality Score is 1 (Below Average). Scores as of 7:27 PM ET, 15 minutes behind.

Are ADMA insiders buying or selling?

One insider bought $251K across 3 filings in the last 6 months. No open-⁠market sales on record. The newest filing: Jerrold B. Grossman, Director, bought $51K on May 27, 2026.

Who are ADMA's biggest insider sellers?

No ADMA insider sold shares on the open market in the last 6 months, as filed on Form 4.

When did an ADMA insider last buy?

Jerrold B. Grossman, Director, bought ADMA shares ($51K) on May 27, 2026, filed May 28, 2026, the newest insider buy on record.

ADMA Biologics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.